Proceedings of the National Academy of Sciences · 2020 · 37 citations · 47 references
Life SciencesNeurobiologyNeuroscienceCellular NeuroscienceMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationProtein Aggregation DisordersAmino AcidsAmyloid Beta AggregationAmyloid Beta PeptidesCell InternalizationCellular Uptake ModulationProtein AggregatesProtein Aggregation In NeuronsTherapeutic Targeting Of Amyloid
Significance Amyloid β (Aβ) aggregation has been the therapeutic target of several Alzheimer’s disease (AD) clinical trials. Aβ exists in many different aggregated forms, making it exceedingly challenging to target. Evidence links intracellular Aβ accumulation and AD pathogenesis. We report that amino acids 1 to 30 of Aβ, Aβ (1–30), do not aggregate yet display cellular uptake stereospecificity when compared to its mirror image, suggesting that Aβ uptake is predominantly receptor-mediated and may be independent from its aggregation state. Additionally, we found Aβ (1–30) internalization to depend on PrP C expression. Aβ (1–30) thus represents a powerful tool to study mechanisms of Aβ cellular internalization and suggests that Aβ uptake could be modulated by therapeutically targeting high-affinity Aβ receptors.
47
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
Salvatore Oddo, Antonella Caccamo, Jason D. Shepherd et al. · Neuron · 2003 · 4.1K citations · Full text
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
Rakez Kayed, Elizabeth Head, Jennifer L. Thompson et al. · Science · 2003 · 4.1K citations
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Laurén, David A. Gimbel, Haakon B. Nygaard et al. · Nature · 2009 · 1.5K citations · Full text
Intraneuronal Aβ42 Accumulation in Human Brain
Gunnar K. Gouras, Julia Tsai, Jan Näslund et al. · American Journal Of Pathology · 2000 · 994 citations · Full text